Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow

T M Wick, J L Moake, M M Udden, S G Eskin, D A Sears, L V McIntire, T M Wick, J L Moake, M M Udden, S G Eskin, D A Sears, L V McIntire

Abstract

The interactions of normal erythrocytes and erythrocytes from patients having hemoglobin S hemoglobinopathies with normal human endothelial cells (EC) were investigated under flow conditions. When EC supernatant, containing 2.8-11.0 U/dl of von Willebrand factor (vWF) antigen and vWF multimeric forms larger than those present in normal plasma, was the red blood cell (RBC)-suspending medium instead of serum-free medium (SFM), the adhesion of sickle RBC, but not normal RBC, to endothelial cells was greatly increased (range of enhancement of sickle RBC adhesion, 2- to 27-fold). Adhesion of sickle RBC to endothelial cells was reduced to near serum-free levels when EC supernatant was immunologically depleted of vWF forms. Sickle RBC suspended in SFM containing 200 U/dl of purified vWF multimers of the type found in normal human plasma or 300 micrograms/ml human fibronectin were only slightly more adhesive to endothelial cells than sickle RBC suspended in SFM alone. These data indicate that unusually large vWF multimers produced by endothelial cells are potent mediators of the adhesion of sickle erythrocytes to endothelial cells. Vaso-occlusive crises in sickle cell anemia may be caused, at least in part, by adhesive interactions between the abnormal surfaces of sickle RBC and the endothelium after the release of unusually large vWF multimeric forms from stimulated or damaged endothelial cells.

References

    1. Anal Biochem. 1966 Apr;15(1):45-52
    1. J Clin Invest. 1973 Nov;52(11):2757-64
    1. J Clin Invest. 1977 Oct;60(4):914-21
    1. Br J Haematol. 1975 Dec;31(4):429-36
    1. J Exp Med. 1978 Jun 1;147(6):1779-91
    1. Blood. 1979 Oct;54(4):872-6
    1. J Clin Invest. 1980 Jan;65(1):154-60
    1. N Engl J Med. 1980 May 1;302(18):992-5
    1. Blood. 1980 Jun;55(6):1056-9
    1. Br J Haematol. 1980 Nov;46(3):499-502
    1. Blood. 1981 Jun;57(6):1140-3
    1. Blood. 1982 Jun;59(6):1272-8
    1. Coll Relat Res. 1981;1(1):95-128
    1. Blood. 1983 Jan;61(1):99-110
    1. Prog Hemost Thromb. 1982;6:139-77
    1. Blood. 1984 Sep;64(3):592-8
    1. Thromb Res. 1984 Aug 15;35(4):431-50
    1. Blood. 1985 Jan;65(1):183-9
    1. Proc Natl Acad Sci U S A. 1985 Jan;82(2):440-4
    1. Blood. 1985 Apr;65(4):823-31
    1. Science. 1985 Jun 21;228(4706):1401-6
    1. Blood. 1985 Sep;66(3):724-7
    1. J Clin Invest. 1985 Oct;76(4):1605-12
    1. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8057-61
    1. Blood. 1986 Nov;68(5):1050-4
    1. Blood. 1986 Nov;68(5):1162-6
    1. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8351-5
    1. J Clin Invest. 1986 Dec;78(6):1456-61
    1. J Cell Biol. 1986 Feb;102(2):449-56
    1. Cell. 1986 Jul 18;46(2):185-90
    1. Blood. 1986 Sep;68(3):732-6
    1. J Clin Invest. 1986 Oct;78(4):1112-9

Source: PubMed

Подписаться